fatetherapeutics.com (FATE) - היקף יתרות המזומנים של החברה

Cash on hand indicates a lack of profitability, as Fate Therapeutics, Inc. (FATE) relies on external funding. The company focuses on developing stem cell-based cancer therapies in the US, leveraging its own scientific capabilities. The value of 0.14 reflects the latest liquidity level supporting automated iPSC cloning platforms, which eliminate manual labor in the mass production of drugs.
פילוחים אנליטיים של חברת Fate Therapeutics, Inc.

This indicator measures the volume of liquid assets, determining the business's ability to fund expansion without resorting to expensive debt capital. The trend is driven by the difference between operating cash flow and capital expenditures. By analyzing the cash on hand for Fate Therapeutics, Inc. (FATE) at the level of 0.14, an investor assesses the resource base for scaling iPSC technologies. Sufficient liquidity ensures Fate Therapeutics, Inc. (FATE) maintains leadership in cancer therapy production and future pricing power.